The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques. (Q53653565)
Jump to navigation
Jump to search
scientific article published in November 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques. |
scientific article published in November 2005 |
Statements
The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques. (English)
B J Nickoloff
K B Gordon
B K Bonish
T Patel
C L Leonardi
1 November 2005
153
5
945-953
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference